01:28 AM EDT, 08/20/2026 (MT Newswires) -- Middle East Pharmaceutical Industries Co. (SASE:4016), d/b/a Avalon Pharma, renewed its credit facilities deal worth 50 million Saudi riyals with Alinma Bank. The Sharia-compliant financing, valid for one year, will fund the pharmaceutical company's working capital and assets, according to a Thursday release.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.